FDA Brief

Warning letters Drugs

FDA warning letter to

Safecor Health, LLC

High riskIssued Sep 5, 2023Posted Sep 12, 2023Division of Pharmaceutical Quality Operations I

FDA warned drug repackager Safecor Health over CGMP failures that let tablets from other drugs contaminate packaging lines.

What happened

FDA inspected Safecor Health's Woburn, Massachusetts drug manufacturing and repackaging facility from March 7 to 16, 2023. Investigators found various capsules and tablets on and under a blister packaging machine while it was packing 81 mg chewable aspirin, even though batch records said the line had been cleared. They also found white powder residue on supposedly clean equipment, untested water used as a drug ingredient, and uncontrolled paper records, including torn and partly filled batch records and correction fluid used on a cleaning log.

What FDA found

  1. The company did not properly check the packaging line before each run, so tablets and capsules from earlier drugs were left on and under the machine during an aspirin run.

    21 CFR 211.130(e)
  2. Cleaning and maintenance procedures for equipment were not adequate, with unidentified white powder left on surfaces called clean and a cleaning requalification that picked drugs at random without scientific reason.

    21 CFR 211.67(b)
  3. The company used purchased water as a drug ingredient but only looked at it, without testing it for identity, purity, strength or microbes.

    21 CFR 211.84(d)(2)
  4. The quality unit did not control paper records: partly completed and torn-up manufacturing records, loose printed forms near the repackaging area, forms printable by many employees, and correction fluid used on a cleaning log.

    21 CFR 211.22

What FDA wants

FDA tells the company to correct the violations promptly and to send a written response, including detailed evaluations and corrective action plans, by September 26, 2023. FDA also recommends hiring a qualified CGMP consultant to audit the whole operation.

Who should pay attention

  • hospital and long-term care pharmacies that buy unit-dose repackaged drugs
  • brands and pharmacies that contract with repackagers
  • companies whose products are repackaged by third parties

This is a summary. Read the original letter on fda.gov.

Safecor Health, LLC's FDA history

Recalls in the last 12 months

Nov 4 Class II Safecor Health, LLC
Drug
Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.
Manufacturer is recalling batches due to co-mingled tablet.
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04
Failed Stability Specifications
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04
Failed Stability Specifications
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04
Failed Stability Specifications
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 5 mg per 10 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0654-16
Failed Stability Specifications
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 5 mg per 1 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0653-04
Failed Stability Specifications
Sep 23 Class II Safecor Health, LLC
Drug
Fluphenazine HCl Elixir, USP, 2.5 mg per 5 mL, Delivers: 5 mL, Oral Elixir, PAI, Alcohol 14% by volume, For Oral Use Only, Rx Only, Pkg by: Safecor Health, Woburn, MA 01801. NDC: 00121-0654-16
Failed Stability Specifications
May 27 Class II Safecor Health, LLC
Drug
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
May 27 Class II Safecor Health, LLC
Drug
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid, Contains: Folic Acid 799 mcg/5mL, Delivers 5 mL per oral syringe, (Nephronex), Mfg By: LLORENS; Pkg by: Safecor, Columbus, OH. NDC 54859-0516-08
Presence of a Foreign Substance; black particles observed in liquid
Dec 10, 2025 Class II Safecor Health, LLC
Drug
Haloperidol Lactate Injection, 5 mg/mL, 25 x 1 mL Single-Dose Vials, Sterile, Rx only, For Intramuscular Use Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26605. NDC: 67457-426-12 with Safecor Health …
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.

Full company page

Similar letters to other companies

  1. MD Pharmaceutical Supply, LLC

    FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.

    High risk
  2. Legacy Pharmaceutical Packaging LLC

    Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.

    High risk